학술논문
AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjects.
Document Type
Article
Author
Source
Cell Death Discovery; 10/30/2023, Vol. 9 Issue 1, p1-12, 12p
Subject
Language
ISSN
20587716